ArticleMolecular therapy. Oncology2024

Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma.

Linfu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.